Story detail view · 2026-07
STAT+: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides

STAT+: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides

Quick Summary

The panel recommended allowing compounding pharmacies to produce popular but unproven BPC-157 and KPV peptides.

Continue Reading on STAT News

Get instant updates on Telegram

Join our channel to receive the latest headlines and breaking stories as soon as they are published.

Join channel

Comments (0)

Join the conversation. Comments are rate-limited, secured, and GDPR-compliant.

No comments yet. Be the first to share your thoughts!

Write a comment

0 / 500